Dianhydrodulcitol
- Generic Name
- Dianhydrodulcitol
- Indication
用于慢性粒细胞白血病、肺癌、骨髓瘤、头颈部肿瘤、鼻咽癌、乳腺癌、卵巢癌及宫颈癌等。
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Phase 2
Recruiting
- Conditions
- Glioblastoma
- Interventions
- First Posted Date
- 2019-05-31
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Global Coalition for Adaptive Research
- Target Recruit Count
- 1030
- Registration Number
- NCT03970447
- Locations
- 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
🇺🇸St. Joseph Hospital, Orange, California, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
Expanded Access to VAL-083
- Conditions
- Cancer
- First Posted Date
- 2017-05-03
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Kintara Therapeutics, Inc.
- Registration Number
- NCT03138629
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath